TLX 2.78% $19.93 telix pharmaceuticals limited

Ann: TLX101 for Glioblastoma Therapy - Clinical Trial Update, page-3

  1. 169 Posts.
    lightbulb Created with Sketch. 28
    Excellent news to cease the preliminary at just 10 patients. Must be showing very good results to cease and to start a proper study.
 
watchlist Created with Sketch. Add TLX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.